Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-014920

President sold 29,675 shares at an average $56.99 ($1,691,056)

  • President acquired 29,675 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
RUBINSTEIN JULIE President 2021-02-24 Option exercise +15,000 $6.55 $98,250 15,000 D: show line 1 in the form
RUBINSTEIN JULIE President 2021-02-24 Sale −4,234 $56.45 $239,009 10,766 D: show line 2 in the form
RUBINSTEIN JULIE President 2021-02-24 Sale −4,134 $57.12 $236,134 6,632 D: show line 3 in the form
RUBINSTEIN JULIE President 2021-02-24 Sale −3,374 $58.74 $198,189 3,258 D: show line 4 in the form
RUBINSTEIN JULIE President 2021-02-24 Sale −3,258 $59.33 $193,297 0 D: show line 5 in the form
RUBINSTEIN JULIE President 2021-02-25 Option exercise +14,675 $6.55 $96,121 14,675 D: show line 6 in the form
RUBINSTEIN JULIE President 2021-02-25 Sale −14,076 $56.13 $790,086 599 D: show line 7 in the form
RUBINSTEIN JULIE President 2021-02-25 Sale −599 $57.33 $34,341 0 D: show line 8 in the form
Open-market sales · 29,675 sh · avg $56.99 · $1,691,056

Table II: Derivative

Insider Date Transaction Shares Price Value Exercise Expires Underlying Owned after D/I
RUBINSTEIN JULIE President 2021-02-24 Option exercise · Stock Option (Right to Buy) −15,000 270,000 D: show line 9 in the form
RUBINSTEIN JULIE President 2021-02-25 Option exercise · Stock Option (Right to Buy) −14,675 255,325 D: show line 10 in the form
Loading xslF345X03/doc4.xml…